Dallas, Texas (PRWEB) April 08, 2014
In this report, the neurovascular interventions market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. In 2013 in the 10MM, the neurovascular interventions market was approximately $ 1.37bn. We estimate the 2014 sales of neurointerventional devices for cerebrovascular applications to be $ 1.40bn across the 10 countries covered in this report, which are the US, France, Germany, Italy, Spain, the UK, Japan, China, India, and Brazil. Embolization, revascularization, and mechanical thrombectomy devices can be used for a wide range of cerebrovascular indications including intracranial aneurysms and arteriovenous malformations (AVMs), dural arteriovenous fistulas (DAVFs), atherosclerotic disease, and stroke. Endovascular therapy for neurovascular applications is rapidly expanding and provides effective results.
Complete Report available at http://www.marketoptimizer.org/medipoint-neurovascular-interventions-global-analysis-and-market-forecasts.html .
The key drivers for this market during the forecast period are: